Pharmaceuticals
Novo Nordisk, Eli Lilly lean on trust as weight-loss drugs wait for liftoff
Makers of generic weight-loss drugs that mimic those such as Eli Lilly’s tirzepatide, branded Mounjaro, have piled into the Indian market after their patents expired. © Reuters
BENGALURU — Ameya Nagarajan forks out nearly 25,000 rupees ($270) every month for weight-loss drugs, 20% more than the average monthly income of a salaried Indian.
